Analysis of five-year survival in TCGA patients with SRCIN1 methylation of all selected differentially methylated CpG sites in unpaired tumor breast tissue revealed that high methylation was associated with shorter survival than low methylation (Figure 3C; p < 0.024). This evidence concerns the gene SRCIN1 and neoplasm.